Biomarkers for Bipolar Disorder: Chaperones and Reticulum Endoplasmatic Stress Response CHAP´s Study

Status

Suspended

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00994630

Acronym

CHAPS

Enrollment

Registered

2009-10-14

Start date

2010-01-31

Completion date

Unknown

Last updated

2011-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disease Type I

Brief summary

The purpose of this study is to determine expression of chaperones proteins from the endoplasmatic reticulum stress response system in bipolar I patients (manic phase) compared to healthy controls. Hypothesis: There is no difference in chaperones proteins expression between bipolar I manic patients and healthy controls

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 55 Years

Healthy volunteers

Yes

Inclusion criteria

* Bipolar Disease type I manic phase * YMRS \> 14 * HDRS \< 9

Exclusion criteria

* Use of lithium, divalproate, or carbamazepine in therapeutic levels over the past 30 days

Countries

Brazil

Outcome results